Cart
sales@molnova.com
Schizandrin B
CAS No. 61281-37-6
Schizandrin B( Wuweizisu B )
Catalog No. M15307 CAS No. 61281-37-6
Schisandrin B(Wuweizisu-B) is a dibenzocyclooctadiene derivative isolated from Fructus Schisandrae.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 72 | In Stock |
|
| 10MG | 116 | In Stock |
|
| 25MG | 219 | In Stock |
|
| 50MG | 392 | In Stock |
|
| 100MG | 569 | In Stock |
|
| 500MG | 1188 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameSchizandrin B
-
NoteResearch use only, not for human use.
-
Brief DescriptionSchisandrin B(Wuweizisu-B) is a dibenzocyclooctadiene derivative isolated from Fructus Schisandrae.
-
DescriptionSchisandrin B(Wuweizisu-B) is a dibenzocyclooctadiene derivative isolated from Fructus Schisandrae, has been shown to produce antioxidant effect on rodent liver and heart.
-
In VitroReal Time qPCR Cell Line:lymphocyte Concentration:10-50 μM Incubation Time:4 h Result:Increase in relative mRNA copy number of Nrf2, HO-1, TrxR1, and GCLC.Increased basal ROS levels and decreased GSH/GSSG ratio.
-
In VivoAnimal Model:Mice endotoxic shock model Dosage:80 mg/kg.Administration:Intraperitoneally injected (i.p.), single dose.Result:Decreased proliferation and secretion of the proinflammatory cytokines IL-2, IL-6, and IFN-g .
-
SynonymsWuweizisu B
-
PathwayCell Cycle/DNA Damage
-
TargetATM/ATR
-
RecptorATR
-
Research AreaNeurological Disease
-
Indication——
Chemical Information
-
CAS Number61281-37-6
-
Formula Weight400.46
-
Molecular FormulaC23H28O6
-
Purity>98% (HPLC)
-
SolubilityEthanol: 10 mg/mL (24.97 mM); DMSO: 80 mg/mL (199.77 mM)
-
SMILESCOC1=C(OC)C(OC)=C2C(CC(C)C(C)CC3=CC4=C(OCO4)C(OC)=C23)=C1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Bunel V, et al. J Appl Toxicol. 2014 Dec;34(12):1311-9.
molnova catalog
related products
-
Camonsertib
Camonsertib (RP-3500) is a novel, potent and selective ATR kinase inhibitor (ATRi) that exhibits potent antitumor effects with an IC50: 1.00 nM in biochemical assays.
-
VE-821
A potent, selective and ATP-competitive inhibitor of ATR with Ki/IC50 of 13 nM/26 nM; shows excellent selectivity for ATR over the related PIKKs ATM, DNA-PK, mTOR and PI3K.
-
AZ-32
AZ32 is an orally bioavailable and blood-brain barrier-penetrating inhibitor of ATM(IC50 of <6.2 nM and 0.31 μM for ATM enzyme and in cell).
